Quantum Biopharma Ltd.
Quantum Biopharma Ltd. (QNTM): 1 pipeline candidate · ~32 mo cash runway · 10 clinical trials. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
32.2 months
D/E 1.19
Lead: Phase 2
1 candidate
N/A
N/A
A transparent, data-derived signal for Quantum Biopharma Ltd.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$25.9M
Cash
$1.9M
Quarterly Burn
$306K
Runway
32.2 mo
Revenue
—
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (1 candidate)
| Drug | Phase |
|---|---|
| fsd201 | Phase 2 |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
20
Total value held
$865K
| Holder | Shares | Value |
|---|---|---|
| advisorshares investments llc | 108,591 | $524K |
| jane street group, llc | 31,501 | $152K |
| citadel advisors llc | 15,863 | $77K |
| marex group plc | 13,468 | $65K |
| osaic holdings, inc. | 6,375 | $31K |
| atlantic union bankshares corp | 1,000 | $5K |
| farther finance advisors, llc | 1,000 | $4K |
| jones financial companies lllp | 700 | $3K |
| cetera trust company, n.a | 250 | $1K |
| wells fargo & company/mn | 100 | $477 |
Showing top 10 of 20 institutional holders of Quantum Biopharma Ltd.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in Quantum Biopharma Ltd.'s pipeline?
Quantum Biopharma Ltd. (QNTM) has 1 pipeline candidate tracked by BioSniper across SEC filings and clinical trial registrations.
What is Quantum Biopharma Ltd.'s lead drug candidate?
Quantum Biopharma Ltd.'s most advanced tracked candidate is fsd201 (Phase 2) for Mast Cell Activation Syndrome.
What is Quantum Biopharma Ltd.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Quantum Biopharma Ltd. has approximately 32.2 months of cash runway.
What is Quantum Biopharma Ltd.'s market capitalization?
Quantum Biopharma Ltd.'s market capitalization is approximately $25.9M.
Who is the CEO of Quantum Biopharma Ltd.?
Mr. Zeeshan Saeed is the chief executive officer of Quantum Biopharma Ltd. (QNTM).
Get the full picture on Quantum Biopharma Ltd.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.